BlueFloat Energy told Thirroul loves the ocean just as it is - without South Pacific Offshore Wind Project | South Coast Register
Wind turbines may be preferred a fair bit further out to sea.
Source: southcoastregister.com.au
📰 Dapto News
Page 55 - Dapto News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dapto. Real-time updates on events, politics, business and more.
Acreage site at Stream Hill for sale with $6m to $7m price guide | Illawarra Mercury
The site has a price guide of $6 million to $7 million.
Source: illawarramercury.com.au
Oppenheimer Increases Aptose Biosciences (NASDAQ:APTO) Price Target to $50.00
Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) had its price target raised by equities researchers at Oppenheimer from $9.00 to $50.00 in a research report issued on Monday, The Fly reports. APTO has been the topic of several other reports. Piper Sandler cut their target price on Aptose Biosciences from $45.00 to $37.00 in a […]
Aptose Biosciences Piper Sandler Renaissance Technologies Royal Bank Annandale Capital Sigma Planning Corp
Source: tickerreport.com
Truckie mum Christie Sinclair sentenced for drink container fight on Dapto exit ramp. | South Coast Register
Court shows mercy to woman who lobbed a Hungry Jacks drink container at a fellow driver.
New South Wales Mark Douglass Holden Barina Nissan El Grande Christie Sinclair Wollongong Local Court On
Source: southcoastregister.com.au
Truckie mum Christie Sinclair sentenced for drink container fight on Dapto exit ramp. | Southern Highland News
Court shows mercy to woman who lobbed a Hungry Jacks drink container at a fellow driver.
Source: southernhighlandnews.com.au
Aptose Biosciences (NASDAQ:APTO) Price Target Cut to $37.00
Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) had its price target decreased by Piper Sandler from $45.00 to $37.00 in a research report released on Wednesday morning, The Fly reports. Other equities research analysts have also recently issued reports about the company. StockNews.com started coverage on Aptose Biosciences in a research note on Monday, June […]
Piper Sandler Aptose Biosciences Aptose Biosciences Inc Annandale Capital Formidable Asset Management Canaccord Genuity Group
Source: modernreaders.com
Aptose Biosciences (NASDAQ:APTO) PT Lowered to $40.00 at Royal Bank of Canada
Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) had its price target lowered by Royal Bank of Canada from $75.00 to $40.00 in a research report report published on Wednesday, The Fly reports. Several other research analysts have also weighed in on the stock. StockNews.com began coverage on shares of Aptose Biosciences in a research note […]
Aptose Biosciences Piper Sandler Sequoia Financial Advisors Annandale Capital Aptose Biosciences Inc Aptose Biosciences Company Profile
Source: themarketsdaily.com
Kamilaroi man Corey Tutt out to 'decolonise the lab coat' | Illawarra Mercury
"He told me ... kids like me don't go to university."
Source: illawarramercury.com.au
Double decker buses return to mainstream Sydney route service
Call it Back to the Future II. Double decker buses will finally be reinstated into mainstream Sydney route service after being dumped 30 years ago.
Source: governmentnews.com.au
StockNews.com Initiates Coverage on Aptose Biosciences (NASDAQ:APTO)
StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) in a report released on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts have also recently commented on APTO. Royal Bank of Canada reiterated an outperform rating and set a $75.00 target price […]
Aptose Biosciences Royal Bank Aptose Biosciences Company Profile Aptose Biosciences Inc Cetera Advisors Sequoia Financial Advisors
Source: kopsource.com